---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-025929"
form_type: "8-K"
ticker: "PPCB"
cik: "0001517681"
company_name: "Propanc Biopharma, Inc."
filed_at: "2024-07-02T23:59:59+00:00"
generated_at: "2026-05-31T23:45:38.668462+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Propanc Biopharma issues $33,750 convertible note with 35% discount for working capital

## Summary
- Issued convertible promissory note to 104 LLC for gross proceeds of $30,375 after $2,500 legal fee deduction.
- Note matures June 20, 2025, bears 10% interest (16% on default), convertible at 65% of lowest closing price over prior 10 days.
- Company can prepay at premiums 110-125% of face within first 180 days; no prepayment right after.
- Net proceeds used for general working capital; issued under Section 4(a)(2)/Rule 506(b) exemption.
- Conversion shares subject to 4.99% beneficial ownership limitation and 500% reserve requirement.

## SEC filing metadata
- accession: 0001493152-24-025929
- form_type: 8-K
- ticker: PPCB
- cik: 0001517681
- company_name: Propanc Biopharma, Inc.
- filed_at: 2024-07-02T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1517681/000149315224025929/0001493152-24-025929-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1517681/000149315224025929/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-025929
- JSON: https://secwatch.observer/filing/0001493152-24-025929.json
- Plain text: https://secwatch.observer/filing/0001493152-24-025929.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.